Home » Newsletters » BioWorld Science

BioWorld Science

July 26, 2007

View Archived Issues

Recent patents disclose novel strategies for the treatment of respiratory disorders

Novel agents intended for the treatment of cardiovascular diseases, claimed in recent patents

Recent patents divulge new options for the treatment of cancer

Alteon to change name to Synvista Therapeutics

Expression's phase Ia study of EGEN-001 for ovarian cancer under way

CTRC begins enrollment for phase II trial of living virus anticancer therapy Reolysin

Qiagen shareholders vote to acquire Digene

Akela completes patient enrollment in Fentanyl Taifun phase IIb trial

Promising preclinical results of Pluristem's PLX cells in limb ischemia

Brookwood and DelSite extend GelSite codevelopment agreement

IDM to amend NDA of L-MTP-PE for osteosarcoma; submits MAA to EMEA

Arius begins preclinical trials of novel CD44-targeting antibody

BioCryst begins phase II trial of intravenous influenza inhibitor peramivir

EntreMed commences leukemia clinical trial for MKC-1

FDA grants fast track designation to Neurochem's drug candidate Alzhemed

CHMP adopts positive opinion of Pfizer's Ecalta for candidiasis

Patient recruitment completed for Isotechnika's pivotal phase III psoriasis trial

Positive results for Advanced Magnetics' fourth phase III trial of ferumoxytol

Short-term UK-453061 monotherapy effectively decreases viral load in HIV-infected patients

Schering-Plough Reports Results for Second Quarter of 2007

rhGH induction-maintenance-reinduction schedule superior to interruption-retreatment for HARS

Eli Lilly's Forsteo for osteoporosis in men approved by European Commission

Kowa Pharmaceutical identifies potent and selective PPARalpha agonists for dyslipidemia

New hepatoselective HMG-CoA reductase inhibitors developed by Pfizer

Raltegravir + tenofovir/lamivudine exhibits rapid, prolonged antiretroviral activity in HIV patients

U.S. DTRA and Peregrine enter contract negotiations for hemorrhagic fever treatments

Targacept initiates phase IIb development of AZD-3480 (TC-1734) for AD

Novel Spiriva Respimat inhaler for COPD completes European approval process

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...